UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005980
Receipt number R000005410
Scientific Title The prospective cohort study of the evaluation of Endoscopic Ultrasound-guided Fine Needle Aspiration for pancreatic solid tumor
Date of disclosure of the study information 2011/07/15
Last modified on 2015/01/10 18:40:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The prospective cohort study of the evaluation of Endoscopic Ultrasound-guided Fine Needle Aspiration for pancreatic solid tumor

Acronym

Endoscopic Ultrasound-guided fine Needle aspiration Of Pancreatic Cancer Study (EUNOS-PC)

Scientific Title

The prospective cohort study of the evaluation of Endoscopic Ultrasound-guided Fine Needle Aspiration for pancreatic solid tumor

Scientific Title:Acronym

Endoscopic Ultrasound-guided fine Needle aspiration Of Pancreatic Cancer Study (EUNOS-PC)

Region

Japan


Condition

Condition

pancreatic solid tumor

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is the evaluation of the efficacy and safety of EUS-FNA for pancreatic solid tumors.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The sensitivity of EUS-FNA for pancreatic solid tumors

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

EUS-FNA

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

# Patients with pancreatic solid tumors
# Patients who understand the aim of this study
# Patients who had not undergone EUS-FNA yet
# Japanese

Key exclusion criteria

# Patients who have tendency of bleeding
# The lesion cannot be demonstrated
# Patients who have the high risk of complication by EUS-FNA
# There are some definite vessels between EUS and lesions
# The movement by breathing may cause puncture of another organs
# Patients with pancreatic cystic lesions
# Patients who don't understand the aim of this study
# EUS-FNA doesn't help to decide the treatment

Target sample size

230


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shigetaka Yoshinaga

Organization

National Cancer Center Hospital

Division name

Endoscopy Division

Zip code


Address

5-1-1 Tsukiji, Chuo-ku, Tokyo

TEL

03-3542-2511

Email

shiyoshi@ncc.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shigetaka Yoshinaga

Organization

National Cancer Center Hospital

Division name

Endoscopy Division

Zip code


Address

5-1-1 Tsukiji, Chuo-ku, Tokyo

TEL

03-3542-2511

Homepage URL


Email

shiyoshi@ncc.go.jp


Sponsor or person

Institute

Clinical application of the new technology for endoscopic diagnosis and researches on the improvement of the diagnostic accuracy

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare
Third Research Project on General Strategy Against Cancer

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立がん研究センター中央病院(東京都)、東京医科大学病院(東京都)、福島県立医科大学附属病院(福島県)、愛知県がんセンター中央病院(愛知県)、岐阜大学医学部附属病院(岐阜県)


Other administrative information

Date of disclosure of the study information

2011 Year 07 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 10 Month 05 Day

Date of IRB


Anticipated trial start date

2010 Year 11 Month 09 Day

Last follow-up date

2014 Year 12 Month 26 Day

Date of closure to data entry

2015 Year 01 Month 10 Day

Date trial data considered complete

2015 Year 01 Month 10 Day

Date analysis concluded



Other

Other related information

We evaluate efficacy and complications of EUS-FNA for pancreatic solid tumors.
We observe about patients&#39; condition 1 week after EUS-FNA.


Management information

Registered date

2011 Year 07 Month 15 Day

Last modified on

2015 Year 01 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005410


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name
2015/01/10 150110EUNOS生データ_デポジトリ用.xlsx